Noile-Immune Biotech Inc.

Tokyo Stock Exchange 4893.T

Noile-Immune Biotech Inc. Free Cash Flow Yield on January 14, 2025: -12.14%

Noile-Immune Biotech Inc. Free Cash Flow Yield is -12.14% on January 14, 2025, a -29.05% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Noile-Immune Biotech Inc. 52-week high Free Cash Flow Yield is -9.25% on July 30, 2024, which is 23.80% above the current Free Cash Flow Yield.
  • Noile-Immune Biotech Inc. 52-week low Free Cash Flow Yield is -14.62% on August 05, 2024, which is -20.39% below the current Free Cash Flow Yield.
  • Noile-Immune Biotech Inc. average Free Cash Flow Yield for the last 52 weeks is -12.05%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Tokyo Stock Exchange: 4893.T

Noile-Immune Biotech Inc.

CEO Mr. Koji Tamada M.D., Ph.D.
IPO Date June 28, 2023
Location Japan
Headquarters 2-12-10
Employees 28
Sector Health Care
Industries
Biotechnology
Description

Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email